BCL2

You have access
Improved Survival of Patients With Chronic Lymphocytic Leukemia Between 1998-2022, Including the Era of Target Therapies With BCL2 and BTK Inhibitors
TAMAR TADMOR, GUY MELAMED, HILEL ALAPI, SIVAM GAZIT, TAL PATALON and LIOR ROKACH

Anticancer Research May 2024, 44 (5) 2109-2115; DOI: https://doi.org/10.21873/anticanres.17016
You have access
Clinicopathologic and Prognostic Significance of Bruton’s Tyrosine Kinase Expression in Diffuse Large B-Cell Lymphoma
YEON BI HAN, JEONG MI YANG, HYUN JUNG KWON, JEONG-OK LEE, JONG SEOK LEE and JIN HO PAIK

Anticancer Research November 2021, 41 (11) 5677-5692; DOI: https://doi.org/10.21873/anticanres.15384
Open Access
Induction of Cross-resistance to ABCB1 Substrates in Venetoclax-resistant Human Leukemia HL60 Cells
YUKO NAKAYAMA, KOHJI TAKARA, TETSUYA MINEGAKI, KAZUHIRO YAMAMOTO, TOMOHIRO OMURA and IKUKO YANO

Anticancer Research September 2021, 41 (9) 4239-4248; DOI: https://doi.org/10.21873/anticanres.15228
You have access
Digital Analysis of BCL2 Expression in Laryngeal Squamous Cell Carcinoma
ARISTEIDIS CHRYSOVERGIS, VASILEIOS S. PAPANIKOLAOU, EVANGELOS TSIAMBAS, VASILEIOS RAGOS, DIMITRIOS PESCHOS and EFTHYMIOS KYRODIMOS

Anticancer Research March 2019, 39 (3) 1253-1257; DOI: https://doi.org/10.21873/anticanres.13235
You have access
Bishydroquinone Renieramycin M Induces Apoptosis of Human Lung Cancer Cells Through a Mitochondria-dependent Pathway
TATCHAKORN PINKHIEN, ARNATCHAI MAIUTHED, SUPAKARN CHAMNI, KHANIT SUWANBORIRUX, NAOKI SAITO and PITHI CHANVORACHOTE

Anticancer Research December 2016, 36 (12) 6327-6333;
You have access
p21^CIP1 Induces Apoptosis via Binding to BCL2 in LNCaP Prostate Cancer Cells Treated with MCS-C3, A Novel Carbocyclic Analog of Pyrrolopyrimidine
KO-WOON CHOI, HYEWON SUH, HA LIM OH, CHONGSUK RYOU and CHUL-HOON LEE

Anticancer Research January 2016, 36 (1) 213-220;
You have access
Suppression of AKT Potentiates Synergistic Cytotoxicity of Apigenin with TRAIL in Anaplastic Thyroid Carcinoma Cells
SI HYOUNG KIM, JUN GOO KANG, CHUL SIK KIM, SUNG-HEE IHM, MOON GI CHOI, HYUNG JOON YOO and SEONG JIN LEE

Anticancer Research December 2015, 35 (12) 6529-6537;
You have access
miR-7 Expression in Serous Ovarian Carcinomas
ANETA SWIERCZ, MAGDALENA CHECHLINSKA, JOLANTA KUPRYJANCZYK, AGNIESZKA DANSONKA-MIESZKOWSKA, ALINA REMBISZEWSKA, KRZYSZTOF GORYCA, MARIUSZ KULINCZAK, MICHALINA ZAJDEL, MARIA SROMEK and JAN KONRAD SIWICKI

Anticancer Research April 2015, 35 (4) 2423-2429;
You have access
Histological Grade (HG) in Invasive Ductal Carcinomas of the Breast of Less than 1 cm: Clinical and Biological Associations During Progression from HG1 to HG3
ÁLVARO RUIBAL, PABLO AGUIAR, MARÍA CARMEN DEL RIO, JOSÉ IGNACIO ARIAS, PRIMITIVA MENÉNDEZ-RODRÍGUEZ, FRANCISCO GUDE and MICHEL HERRANZ

Anticancer Research January 2015, 35 (1) 569-573;
You have access
BH3 Mimetics Inhibit Growth of Chondrosarcoma – A Novel Targeted-therapy for Candidate Models
TAKESHI MORII, KOUKI OHTSUKA, HIROAKI OHNISHI, KAZUO MOCHIZUKI, AKIRA YOSHIYAMA, TAKAYUKI AOYAGI, FRANCIS J. HORNICEK and SHOICHI ICHIMURA

Anticancer Research November 2014, 34 (11) 6423-6430;

Main menu

User menu

Search

BCL2

Pages